Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NasdaqGS:AVGO
Broadcom
|
1337.51 | -41,89% | -29,81% | 619.830,54 | 1,58% | 15,2% |
|
NYSE:MRK
Merck
|
129.29 | -8,69% | 4,69% | 327.466,53 | 2,37% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
123.18 | 16,88% | 39,22% | 190.957,95 | 2% | 15,98% |
|
NYSE:TMO
Thermo Fisher Scientific
|
590.70 | -16,78% | -7,46% | 225.479,83 | 0,26% | 14,15% |
|
SWX:NOVN
Novartis
|
93.07 | 8,5% | 21,92% | 189.900,62 | 3,57% | 4,67% |
|
SWX:ROG
Roche Holding
|
227.80 | 30,46% | 46,37% | 183.894,9 | 4,26% | 0,43% |
|
NYSE:DHR
Danaher
|
251.61 | -16,08% | -4,94% | 186.364,14 | 0,41% | 10,89% |
|
NYSE:ABT
Abbott Laboratories
|
104.77 | 1,76% | 14,42% | 182.261,43 | 2,1% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
308.45 | -11,11% | -2,21% | 165.463,28 | 2,9% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.44 | 9,18% | 39,63% | 161.157,9 | 6% | -9,31% |
|
LSE:GSK
GSK
|
18.10 | 5,36% | 20,88% | 73.812,48 | 3,22% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
45.06 | 58,04% | 68,14% | 91.341,13 | 5,34% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.54 | 21,22% | 30,5% | 84.144,93 | 4,67% | 0,15% |
|
NYSE:A
Agilent Technologies
|
147.76 | 7,06% | 19,11% | 43.301,85 | 0,63% | 14,29% |
|
SWX:LONN
Lonza Group
|
516.40 | -26,74% | -11,32% | 37.241,01 | 0,76% | 0,68% |
|
ENXTAM:DSFIR
DSM-Firmenich
|
104.95 | -58,08% | -42,28% | 27.841,54 | 2,42% | 0% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
210.37 | -11,08% | -1,55% | 17.732,85 | 1,39% | 4,24% |
|
XTRA:SY1
Symrise
|
102.25 | 32,73% | 54,52% | 14.249,76 | 1,08% | 5,43% |
|
ENXTPA:BIM
bioMérieux
|
97.00 | 28,68% | 41,56% | 11.727,37 | 0,86% | 5,62% |
|
NasdaqGS:TECH
Bio-Techne Corp
|
81.97 | 13,35% | 33,19% | 12.548,46 | 0,4% | 11,79% |
